226 related articles for article (PubMed ID: 24562809)
41. Breast cancer targeted chemotherapy based on doxorubicin-loaded bombesin peptide modified nanocarriers.
Wang C; Sun X; Wang K; Wang Y; Yang F; Wang H
Drug Deliv; 2016 Oct; 23(8):2697-2702. PubMed ID: 26203692
[TBL] [Abstract][Full Text] [Related]
42. Exploring the synergistic behavior of paclitaxel and vorinostat upon co-loading in albumin nanoparticles for breast cancer management.
Abhang A; Katari O; Ghadi R; Chaudhari D; Jain S
Drug Deliv Transl Res; 2024 Feb; 14(2):510-523. PubMed ID: 37605040
[TBL] [Abstract][Full Text] [Related]
43. Preparation, characterization, and in vivo study of rhein solid lipid nanoparticles for oral delivery.
Feng H; Zhu Y; Fu Z; Li D
Chem Biol Drug Des; 2017 Nov; 90(5):867-872. PubMed ID: 28432812
[TBL] [Abstract][Full Text] [Related]
44. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
[TBL] [Abstract][Full Text] [Related]
45. Modification of paclitaxel-loaded solid lipid nanoparticles with 2-hydroxypropyl-β-cyclodextrin enhances absorption and reduces nephrotoxicity associated with intravenous injection.
Baek JS; Kim JH; Park JS; Cho CW
Int J Nanomedicine; 2015; 10():5397-405. PubMed ID: 26347363
[TBL] [Abstract][Full Text] [Related]
46. The Anticancer Activity of Complex [Cu2(μ-(C6H5)2CHCOO)3(bipy)2)] (ClO4) -Solid Lipid Nanoparticles on MCF-7 Cells.
Kani I; Dikmen G; Eskiler GG; Cecener G; Tunca B; Egeli U
Curr Drug Deliv; 2016; 13(8):1339-1350. PubMed ID: 26750100
[TBL] [Abstract][Full Text] [Related]
47. Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacokinetic and biodistribution in rats.
Pawar H; Surapaneni SK; Tikoo K; Singh C; Burman R; Gill MS; Suresh S
Drug Deliv; 2016 May; 23(4):1453-68. PubMed ID: 26878325
[TBL] [Abstract][Full Text] [Related]
48. Enhancing the antitumor activity of berberine hydrochloride by solid lipid nanoparticle encapsulation.
Wang L; Li H; Wang S; Liu R; Wu Z; Wang C; Wang Y; Chen M
AAPS PharmSciTech; 2014 Aug; 15(4):834-44. PubMed ID: 24696391
[TBL] [Abstract][Full Text] [Related]
49. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
Soni K; Rizwanullah M; Kohli K
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
[TBL] [Abstract][Full Text] [Related]
50. Supramolecular cisplatin-vorinostat nanodrug for overcoming drug resistance in cancer synergistic therapy.
Xu S; Zhu X; Huang W; Zhou Y; Yan D
J Control Release; 2017 Nov; 266():36-46. PubMed ID: 28893609
[TBL] [Abstract][Full Text] [Related]
51. Novel nanostructured lipid carrier co-loaded with doxorubicin and docosahexaenoic acid demonstrates enhanced in vitro activity and overcomes drug resistance in MCF-7/Adr cells.
Mussi SV; Sawant R; Perche F; Oliveira MC; Azevedo RB; Ferreira LA; Torchilin VP
Pharm Res; 2014 Aug; 31(8):1882-92. PubMed ID: 24522814
[TBL] [Abstract][Full Text] [Related]
52. Pharmacokinetics, tissue distribution and relative bioavailability of geniposide-solid lipid nanoparticles following oral administration.
Wang F; Cao J; Hao J; Liu K
J Microencapsul; 2014; 31(4):382-9. PubMed ID: 24697172
[TBL] [Abstract][Full Text] [Related]
53. Synergistic anticancer activity of combined histone deacetylase and proteasomal inhibitor-loaded zein nanoparticles in metastatic prostate cancers.
Thapa RK; Nguyen HT; Jeong JH; Shin BS; Ku SK; Choi HG; Yong CS; Kim JO
Nanomedicine; 2017 Apr; 13(3):885-896. PubMed ID: 27993720
[TBL] [Abstract][Full Text] [Related]
54. Characterization and evaluation of metformin-loaded solid lipid nanoparticles for celluar and mitochondrial uptake.
Xu Q; Zhu T; Yi C; Shen Q
Drug Dev Ind Pharm; 2016 May; 42(5):701-706. PubMed ID: 26258801
[TBL] [Abstract][Full Text] [Related]
55. Formulation development of linagliptin solid lipid nanoparticles for oral bioavailability enhancement: role of P-gp inhibition.
Shah P; Chavda K; Vyas B; Patel S
Drug Deliv Transl Res; 2021 Jun; 11(3):1166-1185. PubMed ID: 32804301
[TBL] [Abstract][Full Text] [Related]
56. Miconazole-loaded solid lipid nanoparticles: formulation and evaluation of a novel formula with high bioavailability and antifungal activity.
Aljaeid BM; Hosny KM
Int J Nanomedicine; 2016; 11():441-7. PubMed ID: 26869787
[TBL] [Abstract][Full Text] [Related]
57. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
Dudhipala N; Janga KY; Gorre T
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
[TBL] [Abstract][Full Text] [Related]
58. [Cytological Study in vitro on Co-delivery of siRNA and Paclitaxel within Solid Lipid Nanoparticles to Overcome Multidrug Resistance in Tumors].
Huang R; Yao X; Chen Y; Sun X; Lin Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2016 Feb; 33(1):108-14. PubMed ID: 27382749
[TBL] [Abstract][Full Text] [Related]
59. Development of levosulpiride-loaded solid lipid nanoparticles and their
Khaleeq N; Din FU; Khan AS; Rabia S; Dar J; Khan GM
J Microencapsul; 2020 Mar; 37(2):160-169. PubMed ID: 31916886
[TBL] [Abstract][Full Text] [Related]
60. Controlled release and reversal of multidrug resistance by co-encapsulation of paclitaxel and verapamil in solid lipid nanoparticles.
Baek JS; Cho CW
Int J Pharm; 2015 Jan; 478(2):617-24. PubMed ID: 25510604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]